Stock Analiz

Immunic, Inc. (IMUX) stock forecast and price target

Price $7.52 · data as of November 13, 2026

12-month price target

Average target$42.64
Upside / downside+467.0%
Analysts11
ConsensusStrong buy
Low $20.00Average $42.64High $85.00

Gold marker: average target · white marker: today’s price ($7.52)

Analyst ratings

Strong buy 0Buy 13Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.60+42.0%$0
Next fiscal year
ends December 31, 2027
$-2.39+33.5%$0
Next quarter
ends December 31, 2026
$-0.76−8.4%$0
Quarter after
ends March 31, 2027
$-0.72+33.3%$0

Consensus of the analysts covering Immunic, updated daily. In the last 30 days 6 estimates were raised and 3 lowered.

Frequently asked questions

What is the Immunic stock price target?

The average 12-month target from 11 analysts is $42.64, 467.0% above the current price of $7.52 Targets range from $20.00 to $85.00.

Is Immunic a buy according to analysts?

The consensus rating is “Strong buy” (13 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Immunic expected to earn?

Analysts expect EPS of $-3.60 for the fiscal year ending December 31, 2026 and $-2.39 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.